Sign in
4

Changes in Ownership

AMGEN INC Filed Acc 0001127602-25-013778

EVP, R&D, & Chief Sci. Officer acquired 3,549 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bradner James E. EVP, R&D, & Chief Sci. Officer 2025-05-06 Grant or award +3,549 29,753 D
Derivatives
Bradner James E. EVP, R&D, & Chief Sci. Officer 2025-05-06 Grant or award · Nqso (Right to Buy) +22,944 $270.44 $6,204,975 22,944 D
Loading xslF345X05/form4.xml…